title: [Arsenic and respiratory neoplasms, risks, prevention].
abstract: Arsine and in general airborne arsenic compounds show the main cancer promoting characteristics. Protection of employees is therefore a question of ventilation speed and arsenic determination in ambient air and, preservated with EDTA, in urine. Meanwhile, the excess of respiratory cancers alone will continue to increase 5% for each microgram of arsenic present per m3 of air breathed in the work area, or excreted in every one-third liter of urine. Eighteen years after occupational lung cancer due to arsenic and arsenic compounds has been recognised in Japan, the presently accepted TLV of arsine, 200 micrograms/m3, unchanged since 1950, thus corresponds to an excess mortality of 1000%.
authors.forename: Y
authors.initials: Y
authors.lastname: Hubert
authors.forename: J M
authors.initials: JM
authors.lastname: Dupont
authors.forename: J
authors.initials: J
authors.lastname: Humbert
mesh_terms: D001151:Arsenic / Q000009:adverse effects* / Q000652:urine; D006801:Humans; D008175:Lung Neoplasms / Q000139:chemically induced* / Q000517:prevention & control; D009784:Occupational Diseases / Q000139:chemically induced* / Q000517:prevention & control; D012307:Risk Factors
chemical_list: D001151:Arsenic
vernacular_title: Arsenic et cancers respiratoires, risques, prévention.